Prevalence and General Medications Utilization, Cost Minimization Analysis of Drugs in Hepatic Impairment Patients at A Tertiary Care Hospital

The World Health Organization (WHO) in 1997 defined drug utilization as the marketing, distribution, prescription, and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequence [1]. The virtual explosion in the marketing of new drugs, the wide variati...

Full description

Saved in:
Bibliographic Details
Published in:Research journal of pharmacy and technology 2019-10, Vol.12 (10), p.4873-4878
Main Authors: Kumar, V. Sathish, Rahaman, SK. Abdul, Deepika, T., kumar, CH. Manoj
Format: Article
Language:English
Subjects:
Age groups
Analgesics
Antibiotics
Brand names
Data analysis
Drug dosages
Drug use
Generic drugs
Health care expenditures
Hospitals
Intensive care
Liver cirrhosis
Marketing
Medicine
Mortality
Pancreatitis
Patients
Pharmaceuticals
Prescription drugs
Rationality
Studies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The World Health Organization (WHO) in 1997 defined drug utilization as the marketing, distribution, prescription, and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequence [1]. The virtual explosion in the marketing of new drugs, the wide variations in the patterns and extent of drug prescribing, the growing concern about Adverse drug reactions and cost of drugs has led the health professionals to conduct drug utilization studies [1]. Cost minimization analysis is the method of cost evaluation to a certain dose of a drug which has to be administered [13]. [...]this method is useful for distinguishing the generic entities of the same drug having different costs. The results are evident that maximum cases of Hepatic Impairment were found to be pancreatitis 61(30.5%), followed by CLD > Cholelithiasis > Hepatitis > ALD > Jaundice > Metabolic Encephalopathy > Bile Duct Injury > Cirrhosis [table 2].
ISSN:0974-3618
0974-360X
0974-306X
DOI:10.5958/0974-360X.2019.00844.8